PORTLAND, Maine --(BUSINESS WIRE)--Dec. 8, 2022-- Covetrus® , a global leader in animal-health technology and services, today announced the appointment of Ajoy Karna as executive vice president and chief financial officer. Karna succeeds Matthew Foulston , who announced previously his retirement

Portland, Maine (October 13, 2022) – Covetrus (“Covetrus” or the “Company”), a global leader in animal-health technology and services, today announced the successful completion of its previously announced acquisition by funds affiliated with Clayton, Dubilier & Rice (CD&R) and TPG Capital, 

PORTLAND, Maine --(BUSINESS WIRE)--Sep. 26, 2022-- Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer , reporting to Ben Wolin , President and Chief Executive Officer at Covetrus .

PORTLAND, Maine --(BUSINESS WIRE)--Aug. 26, 2022-- Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Margie B. Pritchard as General Counsel and Corporate Secretary, reporting to Ben Wolin , President and Chief Executive Officer

PORTLAND, Maine --(BUSINESS WIRE)--Aug. 11, 2022-- Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that Matthew Foulston , the Company’s Executive Vice President and Chief Financial Officer, has informed the company that he will be retiring from

Second quarter 2022 net sales of $1.22 billion , an increase of 2% year-over-year; GAAP net loss attributable to Covetrus of $(4) million Non-GAAP organic net sales growth of 5% year-over-year Non-GAAP adjusted EBITDA was flat year-over-year at $66 million , including a $2 million year-over-year

PORTLAND, Maine --(BUSINESS WIRE)--Jul. 28, 2022-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2022 results before the markets open on Thursday, August 4, 2022 .

Veterinary survey respondents in North America report that Covetrus Pulse   is simple to use and saves time amid worker shortages and burnout. PORTLAND, Maine --(BUSINESS WIRE)--Jul. 26, 2022-- Covetrus Pulse™ saves time and is easy to implement, finds a new customer survey by Covetrus ® (NASDAQ:

Covetrus Shareholders to Receive $21.00 per Share in Cash Represents a 39% premium to Covetrus’ unaffected 30-day VWAP as of May 13, 2022 PORTLAND, Maine --(BUSINESS WIRE)--May 25, 2022-- Covetrus® (NASDAQ: CVET) (“Covetrus” or the “Company”), a global leader in animal-health technology and

Today, affiliates of CD&R and TPG Global, LLC (together, the “Sponsors”) made a proposal to acquire all of the outstanding shares of Covetrus’ common stock that are not owned by the Sponsors or their affiliates for cash consideration of $21.00 per share.